Overall, beta-amyloid and tau PET imaging offers diagnostic accuracy in the moderate-to-high range for distinguishing PD, DLB, and PSP, and may become increasingly useful as a complementary tool for differential diagnosis in parkinsonian syndromes. This evidence concerns the gene MAPT and Lewy body dementia.